Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA accepts Merck & Co.'s NDA for fixed-dose raltegravir and lamivudine

June 26, 2014

Irish and Belgian university researchers report novel HIV-1 RT inhibitors

June 18, 2014

ViiV Healthcare and Janssen to develop single-tablet regimen for HIV

June 16, 2014

Array BioPharma patents detail novel Trk-A inhibitors

June 12, 2014

Novel HIV-infected, humanized mouse model developed with antiviral PK/PD capabilities

June 11, 2014

Novel agents for HIV infection disclosed by Belgian team

June 10, 2014

DuoGel designed for vaginal and rectal delivery of anti-HIV microbicides

June 6, 2014

Award to support trial of Sangamo's ZFP therapeutic for HIV/AIDS

June 4, 2014

Early clinical results presented for lentiviral-based anti-HIV therapeutic vaccine

June 4, 2014

Fullerene polyaminocaproic acid -- new potent anti-HIV drug candidate

June 3, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...